Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson's Disease
100%
Dystonia
21%
Huntington's Disease
19%
Positron Emission Tomography/computed Tomography (PET/CT)
18%
Alpha-synuclein (α-syn)
17%
Parkinsonism
15%
L-DOPA
13%
Deep Brain Stimulation
13%
Alzheimer's Disease
11%
Alzheime's Disease
11%
Cervical Dystonia
11%
Radioligand
11%
Radiotracer
10%
Striatal
9%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
9%
Unified Parkinson's Disease Rating Scale (UPDRS)
9%
Manganese
9%
Idiopathic Parkinson's Disease
8%
Dopamine
8%
Manganese Exposure
7%
Receptor Binding
7%
Vesicular Acetylcholine Transporter (VAChT)
7%
Patients with Parkinson's Disease
7%
Parkinson Patients
7%
Sphingosine-1-phosphate Receptor (S1PR)
6%
D2 Receptor
6%
Striatum
6%
95% Confidence Interval
6%
Age of Onset
6%
Neurodegenerative Diseases
6%
Tremor
6%
Striatal Dopamine
6%
Regional Cerebral Blood Flow (rCBF)
5%
Movement Disorders
5%
Leucine-rich Repeat Kinase 2 (LRRK2)
5%
Blepharospasm
5%
In Vitro Evaluation
5%
Subthalamic nucleus
5%
Functional Magnetic Resonance Imaging
5%
Odds Ratio
5%
Medicare Beneficiaries
5%
Gait
5%
Basal Ganglia
5%
Dementia
5%
Neuroscience
Parkinson's Disease
74%
Dystonia
22%
Positron Emission Tomography
18%
Dopamine
15%
Fluorine-18
15%
Deep Brain Stimulation
14%
In Vivo
13%
Huntington's Disease
11%
Parkinsonism
11%
Alzheimer's Disease
11%
Positron Emission Tomography
10%
Synuclein
9%
Receptor
9%
Dopaminergic
9%
Tremor
9%
Subthalamic Nucleus
8%
Behavior (Neuroscience)
8%
L-DOPA
8%
Neurodegenerative Disorder
8%
Spasmodic torticollis
7%
Genetics
7%
Stereotypic Movement Disorder
7%
Gait
7%
Radioligand
7%
Amyloid Protein
7%
In Vitro
6%
Macaca
6%
Striatum
6%
Putamen
5%
Receptor Binding
5%
Cerebellum
5%
Functional Connectivity
5%
Basal Ganglia
5%
Magnetic Resonance Imaging
5%
Biological Marker
5%